Pelthos Therapeutics Inc.
PTHS
$36.31
$1.564.49%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 229.50K | -272.30K | 0.00 | 609.00K | 243.50K |
| Gross Profit | -229.50K | 272.30K | 0.00 | -609.00K | -243.50K |
| SG&A Expenses | 7.53M | 6.56M | 6.39M | 6.44M | 6.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.94M | 7.47M | 7.57M | 9.63M | 8.87M |
| Operating Income | -8.94M | -7.47M | -7.57M | -9.63M | -8.87M |
| Income Before Tax | -9.04M | -7.36M | -7.96M | -10.07M | -9.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.04 | -7.36 | -7.96 | -10.07 | -9.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.04M | -7.36M | -7.96M | -10.07M | -9.79M |
| EBIT | -8.94M | -7.47M | -7.57M | -9.63M | -8.87M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -14.71 | -12.40 | -14.65 | -31.56 | -43.08 |
| Normalized Basic EPS | -9.59 | -8.14 | -9.55 | -20.12 | -26.92 |
| EPS Diluted | -14.71 | -12.40 | -14.65 | -31.56 | -43.08 |
| Normalized Diluted EPS | -9.59 | -8.14 | -9.55 | -20.12 | -26.92 |
| Average Basic Shares Outstanding | 2.44M | 2.37M | 2.23M | 1.83M | 1.35M |
| Average Diluted Shares Outstanding | 2.44M | 2.37M | 2.23M | 1.83M | 1.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |